Raymond James & Associates’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.34M	Sell	161,380 -745	-0.5%	-$5.83K	﹤0.01%	2489
2024 Q2	$1.03M	Sell	162,125 -2,963	-2%	-$18.8K	﹤0.01%	2608
2024 Q1	$1M	Buy	165,088 +3,451	+2%	+$19.5K	﹤0.01%	2591
2023 Q4	$981K	Sell	161,637 -19,750	-11%	-$88K	﹤0.01%	2531
2023 Q3	$765K	Buy	181,387 +20,000	+12%	+$74.6K	﹤0.01%	2627
2023 Q2	$500K	Hold	161,387	–	–	﹤0.01%	2944
2023 Q1	$224K	Hold	161,387	–	–	﹤0.01%	3430
2022 Q4	$321K	Hold	161,387	–	–	﹤0.01%	3174
2022 Q3	$326K	Sell	161,387 -4,586	-3%	-$12.9K	﹤0.01%	3129
2022 Q2	$528K	Sell	165,973 -2,000	-1%	-$7.25K	﹤0.01%	2884
2022 Q1	$700K	Sell	167,973 -4,500	-3%	-$19.9K	﹤0.01%	2847
2021 Q4	$826K	Sell	172,473 -2,579	-1%	-$12.9K	﹤0.01%	2752
2021 Q3	$935K	Buy	175,052 +2,000	+1%	+$10.1K	﹤0.01%	2623
2021 Q2	$886K	Buy	173,052 +3,000	+2%	+$17.1K	﹤0.01%	2673
2021 Q1	$1.14M	Sell	170,052 -3,967	-2%	-$22K	﹤0.01%	2413
2020 Q4	$795K	Sell	174,019 -210	-0.1%	-$931	﹤0.01%	2489
2020 Q3	$676K	Buy	174,229 +6,465	+4%	+$27.6K	﹤0.01%	2431
2020 Q2	$799K	Buy	167,764 +250	+0.1%	+$1.03K	﹤0.01%	2310
2020 Q1	$583K	Buy	167,514 +37,000	+28%	+$157K	﹤0.01%	2313
2019 Q4	$629K	Buy	130,514 +32,880	+34%	+$114K	﹤0.01%	2564
2019 Q3	$283K	Buy	97,634 +53,941	+123%	+$188K	﹤0.01%	3045
2019 Q2	$313K	Buy	43,693 +5,799	+15%	+$59.3K	﹤0.01%	2987
2019 Q1	$537K	Sell	37,894 -9,041	-19%	-$119K	﹤0.01%	2602
2018 Q4	$635K	Sell	46,935 -11,860	-20%	-$214K	﹤0.01%	2383
2018 Q3	$1.3M	Buy	58,795 +14,834	+34%	+$312K	﹤0.01%	2074
2018 Q2	$721K	Buy	+43,961	New	+$771K	﹤0.01%	2423